Ryan Institute at URI Receives Approval for Clinical Trial Targeting the Blood Vessels in Alzheimer’s Disease
University of Rhode IslandIn a pioneering clinical trial that will attack Alzheimer’s disease by targeting inflammation in the brain’s blood vessels, researchers at the George & Anne Ryan Institute for Neuroscience have received regulatory approval to initiate the BEACON Study.